Should You Buy Tilray Inc. (TSX:TLRY) or Canopy Growth Corp (TSX:WEED) Stock?

Tilray Inc. (NASDAQ:TLRY) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are leading the cannabis industry. Is one a better bet right now?

| More on:
lush marijuana plants

Cannabis stocks are enjoying a nice recovery to start 2019, and investors are wondering which marijuana companies might be the best picks right now.

Let’s take a look at Tilray (NASDAQ:TLRY) and Canopy Growth (TSX:WEED)(NYSE:CGC) to see if one deserves to be in your portfolio.

Tilray

Based in British Columbia, Tilray remained private for longer than most of its peers, but when it finally decided to list on the NASDAQ, the stock quickly became a big hit among American investors. The decision to list in the U.S. gave Tilray much greater exposure to a wider investing audience, but also set it up for more volatility.

The stock went public near US$20 in July and quickly moved higher, as enthusiasm grew around the marijuana sector. By early September, it was above US$100 per share and hit an intraday high of US$300 on news that the company had received approval to send marijuana to the U.S. for a medical research program.

Shortly afterwards, the Canadian recreational launch came up short on supplies, and that sent the entire sector into a tailspin. Tilray fell from US$200 per share in September to a closing low near US$66 in December. Since then, the stock has drifted higher and currently trades at US$85.

A number of developments have given the stock some near-term stability. Tilray has announced partnerships with large international pharmaceutical and beverage companies to develop products for the medical and recreational markets that are expected to open around the world.

Despite the new enthusiasm, the stock remains extremely expensive based on its current revenue stream, and investors should anticipate ongoing volatility.

Canopy Growth

Canopy Growth is widely viewed as the leader in the cannabis sector, partly due to the endless marketing of the company by its likable CEO.

Canopy has also taken measured steps over the past few years to build a solid base across a wide spectrum of opportunities in the cannabis sector. The company made strategic acquisitions in both the branded goods and medical research segments. In addition, Canopy Growth sold a 38% stake to Constellation Brands, a beer and spirits company, for more than $5 billion. The two firms are developing cannabis-infused beverages for the upcoming Canadian edibles market.

On the medical side, Canopy Growth is the leading player in Canada with the largest list of registered medical marijuana patients.

In the United States, Canopy Growth just received a licence to grow hemp in New York. This is viewed as a big step for the industry and the company, as the U.S. is widely expected to eventually make the sale of marijuana legal at the federal level.

Canopy Growth has a distribution business in Europe and is building large production facilities in the region. It has also established operations or partnerships in Australia and South America.

The stock hit a high around $76 in October before sliding to $36 in late December. The recent rally has the share price back above $55.

Is one a better bet?

Both Tilray and Canopy Growth should emerge as top names in the sector once all the dust settles and the weaker players get squeezed out.

If you only choose one, I would probably make Canopy Growth the first pick right now based on the Constellation Brands investment and the strong position in both medical and recreational segments in Canada and abroad.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

how to save money
Investing

The Best TSX Stock for Canadians to Buy With $1,000 Right Now

iShares S&P/TSX 60 Index ETF (TSX:XIU) could be a great starter investment for new investors in Canada.

Read more »

Canadian dollars are printed
Dividend Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Toronto-Dominion Bank (TSX:TD) stock could do well in the year ahead.

Read more »

monthly desk calendar
Dividend Stocks

Monthly Income: Top Dividend Stocks to Buy in November

Here are two of the best monthly dividend stocks in Canada you can buy in November 2024 and hold for…

Read more »

hand stacks coins
Investing

A Top TSX Stock to Buy Now for Real Wealth Later

Intact Financial (TSX:IFC) stock is a fantastic dividend-growth play for the next 15 years and beyond.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, November 14

The U.S. wholesale inflation data and Fed chair Jerome Powell’s remarks about the economy will remain on TSX investors’ radar…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn Ultimate Passive Income

If you have a TFSA, then you have the key to creating ultimate passive income. All you need is a…

Read more »